Detalhe da pesquisa
1.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Kidney Int
; 103(1): 207-217, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36007597
2.
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.
Kidney Int Rep
; 6(4): 1088-1098, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33912759
3.
End Points for Clinical Trials in Primary Hyperoxaluria.
Clin J Am Soc Nephrol
; 15(7): 1056-1065, 2020 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32165440
4.
Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635).
J Bone Miner Res
; 34(9): 1609-1618, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31063613
5.
Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection.
Diabetes
; 53(4): 877-81, 2004 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15047601
6.
Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.
Endocr Pract
; 10(1): 10-7, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15251616
7.
Response to the Letter, entitled 'Sevoflurane interferes with INO delivery from the INOmax DS machine'.
Paediatr Anaesth
; 19(8): 801-2, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19624371